Anti-ADAR antibody (1172-1221 aa) (STJ91483)
SPECIFICATIONS
ClonalityPolyclonal
HostRabbit
ConjugationUnconjugated
IsotypeIgG
ImmunogenThe antiserum was produced against synthesized peptide derived from the human ADAR1 at the amino acid range 1172-1221
General Information
| Short Description | Rabbit polyclonal anti-Double-stranded RNA-specific adenosine deaminase (1172-1221 aa) for use in IHC, IF, WB and ELISA in Human, Mouse and Rat samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | IHC/IF/WB/ELISA |
| Host | Rabbit |
| Reactivity | Human/Mouse/Rat |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Polyclonal |
| Isotype | IgG |
| Conjugation | Unconjugated |
| Concentration | 1 mg/mL |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Dilution Range | WB 1:500-2000IHC 1:100-1:300ELISA 1:20000IF 1:50-200 |
| Formulation | Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Storage Instruction | Store at-20ยฐC for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Target Information
| Gene Symbol | ADAR |
| Gene ID | 103 |
| Uniprot ID | DSRAD_HUMAN |
| Immunogen | The antiserum was produced against synthesized peptide derived from the human ADAR1 at the amino acid range 1172-1221 |
| Immunogen Region | 1172-1221 aa |
| Specificity | ADAR1 Polyclonal Antibody detects endogenous levels of ADAR1 protein. |
Additional Info
| Post Translational Modifications | Sumoylation reduces RNA-editing activity. |
| Function | Catalyzes the hydrolytic deamination of adenosine to inosine in double-stranded RNA (dsRNA) referred to as A-to-I RNA editing. This may affect gene expression and function in a number of ways that include mRNA translation by changing codons and hence the amino acid sequence of proteins since the translational machinery read the inosine as a guanosine.pre-mRNA splicing by altering splice site recognition sequences.RNA stability by changing sequences involved in nuclease recognition.genetic stability in the case of RNA virus genomes by changing sequences during viral RNA replication.and RNA structure-dependent activities such as microRNA production or targeting or protein-RNA interactions. Can edit both viral and cellular RNAs and can edit RNAs at multiple sites (hyper-editing) or at specific sites (site-specific editing). Its cellular RNA substrates include: bladder cancer-associated protein (BLCAP), neurotransmitter receptors for glutamate (GRIA2) and serotonin (HTR2C) and GABA receptor (GABRA3). Site-specific RNA editing of transcripts encoding these proteins results in amino acid substitutions which consequently alters their functional activities. Exhibits low-level editing at the GRIA2 Q/R site, but edits efficiently at the R/G site and HOTSPOT1. Its viral RNA substrates include: hepatitis C virus (HCV), vesicular stomatitis virus (VSV), measles virus (MV), hepatitis delta virus (HDV), and human immunodeficiency virus type 1 (HIV-1). Exhibits either a proviral (HDV, MV, VSV and HIV-1) or an antiviral effect (HCV) and this can be editing-dependent (HDV and HCV), editing-independent (VSV and MV) or both (HIV-1). Impairs HCV replication via RNA editing at multiple sites. Enhances the replication of MV, VSV and HIV-1 through an editing-independent mechanism via suppression of EIF2AK2/PKR activation and function. Stimulates both the release and infectivity of HIV-1 viral particles by an editing-dependent mechanism where it associates with viral RNAs and edits adenosines in the 5'UTR and the Rev and Tat coding sequence. Can enhance viral replication of HDV via A-to-I editing at a site designated as amber/W, thereby changing an UAG amber stop codon to an UIG tryptophan (W) codon that permits synthesis of the large delta antigen (L-HDAg) which has a key role in the assembly of viral particles. However, high levels of ADAR1 inhibit HDV replication. |
| Protein Name | Double-Stranded Rna-Specific Adenosine DeaminaseDrada136 Kda Double-Stranded Rna-Binding ProteinP136Interferon-Inducible Protein 4Ifi-4K88dsrbp |
| Database Links | Reactome: R-HSA-75102Reactome: R-HSA-77042Reactome: R-HSA-909733Reactome: R-HSA-9833482 |
| Cellular Localisation | Isoform 1: CytoplasmNucleusShuttles Between The Cytoplasm And NucleusNuclear Import Is Mediated By Tnpo1Isoform 5: CytoplasmNucleolusPredominantly Nuclear But Can Shuttle Between Nucleus And CytoplasmTnpo1 Can Mediate Its Nuclear Import Whereas Xpo5 Can Mediate Its Nuclear Export |
| Alternative Antibody Names | Anti-Double-Stranded Rna-Specific Adenosine Deaminase antibodyAnti-Drada antibodyAnti-136 Kda Double-Stranded Rna-Binding Protein antibodyAnti-P136 antibodyAnti-Interferon-Inducible Protein 4 antibodyAnti-Ifi-4 antibodyAnti-K88dsrbp antibodyAnti-ADAR antibodyAnti-ADAR1 antibodyAnti-DSRAD antibodyAnti-G1P1 antibodyAnti-IFI4 antibody |
Information sourced from Uniprot.org